WallStSmart
PALI

Palisade Bio Inc

NASDAQ: PALI · HEALTHCARE · BIOTECHNOLOGY

$1.87
+3.76% today

Updated 2026-06-03

Market cap
$293.69M
P/E ratio
14.08
P/S ratio
11.78x
EPS (TTM)
$0.12
Dividend yield
52W range
$1 – $3
Volume
4.0M

Palisade Bio Inc (PALI) Insider transactions

Net insider activity
Net buying (23,403,833 shares)
Buy transactions
61
Sell transactions
39

All transactions

DateInsiderTitleTypeSharesPriceValue
2026-02-12JONES, MITCHELL LAWRENCEChief Medical OfficerSale1,989$1.75$3480.75
2026-02-12FINLEY, JOHN DAVIDDirector, CEO, CFOSale3,896$1.75$6818.00
2026-02-11JONES, MITCHELL LAWRENCEChief Medical OfficerSale8,000
2026-02-11JONES, MITCHELL LAWRENCEChief Medical OfficerBuy8,000
2026-02-11FINLEY, JOHN DAVIDDirector, CEO, CFOSale13,333
2026-02-11FINLEY, JOHN DAVIDDirector, CEO, CFOBuy13,333
2026-02-09JONES, MITCHELL LAWRENCEChief Medical OfficerBuy787,000
2026-02-09FINLEY, JOHN DAVIDDirector, CEO, CFOBuy2,011,000
2026-01-16WILLIAMS, DONALD ALLENDirectorBuy5,000$1.67$8356.00
2026-01-09WILLIAMS, DONALD ALLENDirectorBuy5,000$1.88$9400.00
2025-10-06WILLIAMS, DONALD ALLENDirectorBuy1,538,700
2025-10-06WILLIAMS, DONALD ALLENDirectorBuy182,000
2025-10-06WEI, BINXIANDirectorBuy510,700
2025-10-06WEI, BINXIANDirectorBuy60,600
2025-10-06JONES, MITCHELL LAWRENCEChief Medical OfficerBuy7,665,800
2025-10-06FINLEY, JOHN DAVIDDirector, CEO, CFOBuy9,179,400
2025-10-06CHUANG, EMILDirectorBuy510,700
2025-10-06CHUANG, EMILDirectorBuy60,600
2025-09-04WILLIAMS, DONALD ALLENDirectorBuy64,400
2025-09-04WEI, BINXIANDirectorBuy18,800
2025-09-04JONES, MITCHELL LAWRENCEChief Medical OfficerBuy289,000
2025-09-04FINLEY, JOHN DAVIDDirector, CEO, CFOBuy323,400
2025-09-04CHUANG, EMILDirectorBuy18,800
2025-07-18CHUANG, EMILDirectorBuy8,000
2025-02-11JONES, MITCHELL LAWRENCEChief Medical OfficerBuy29,000
2025-02-11JONES, MITCHELL LAWRENCEChief Medical OfficerBuy24,000
2025-02-11FINLEY, JOHN DAVIDDirector, CEO, CFOBuy47,000
2025-02-11FINLEY, JOHN DAVIDDirector, CEO, CFOBuy40,000
2024-11-21WILLIAMS, DONALD ALLENDirectorBuy388
2024-11-21WEI, BINXIANDirectorBuy388
2024-07-11WILLIAMS, DONALD ALLENDirectorBuy2,100
2024-07-11WEI, BINXIANDirectorBuy2,100
2024-07-11FISCHBEIN, MARGERY B.DirectorBuy2,100
2024-06-11WILLIAMS, DONALD ALLENDirectorBuy340
2024-06-11WEI, BINXIANDirectorBuy465
2024-05-28WILLIAMS, DONALD ALLENDirectorBuy1,000$4.86$4863.00
2024-05-28JONES, MITCHELL LAWRENCEChief Medical OfficerSale2,735
2024-05-28JONES, MITCHELL LAWRENCEChief Medical OfficerSale1,555
2024-05-28JONES, MITCHELL LAWRENCEChief Medical OfficerBuy2,735
2024-05-28JONES, MITCHELL LAWRENCEChief Medical OfficerBuy1,555
2024-05-28JONES, MITCHELL LAWRENCEChief Medical OfficerSale810$4.76$3855.60
2024-05-28JONES, MITCHELL LAWRENCEChief Medical OfficerSale461$4.76$2194.36
2024-05-28FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorSale3,335
2024-05-28FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorSale2,111
2024-05-28FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorSale1,622
2024-05-28FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorBuy3,335
2024-05-28FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorBuy2,111
2024-05-28FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorBuy1,622
2024-05-28FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorSale959$4.76$4564.84
2024-05-28FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorSale607$4.76$2889.32
2024-05-28FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorSale467$4.76$2222.92
2024-05-24FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorBuy1,000$4.81$4810.00
2024-05-20FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorBuy666$4.97$3311.68
2024-05-06JONES, MITCHELL LAWRENCECEO, CFO, DirectorSale304
2024-05-06JONES, MITCHELL LAWRENCECEO, CFO, DirectorSale156
2024-05-06JONES, MITCHELL LAWRENCECEO, CFO, DirectorBuy304
2024-05-06JONES, MITCHELL LAWRENCECEO, CFO, DirectorBuy156
2024-05-06JONES, MITCHELL LAWRENCECEO, CFO, DirectorSale90$8.46$761.40
2024-05-06JONES, MITCHELL LAWRENCECEO, CFO, DirectorSale47$8.46$397.62
2024-05-06FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorSale232
2024-05-06FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorSale211
2024-05-06FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorBuy232
2024-05-06FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorBuy211
2024-05-06FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorSale67$8.46$566.82
2024-05-06FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorSale61$8.46$516.06
2024-03-11FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorSale5,558
2024-03-11FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorBuy5,558
2024-02-09NEAL, JAMES RDirectorSale5,820
2024-02-09NEAL, JAMES RDirectorSale5,100
2024-02-09NEAL, JAMES RDirectorBuy5,820
2024-02-09NEAL, JAMES RDirectorBuy5,100
2024-02-09NEAL, JAMES RDirectorBuy12,160
2024-02-09NEAL, JAMES RDirectorSale6,880
2024-02-08TRENSCHEL, ROBERT J.DirectorSale5,820
2024-02-08TRENSCHEL, ROBERT J.DirectorSale5,100
2024-02-08TRENSCHEL, ROBERT J.DirectorBuy5,820
2024-02-08TRENSCHEL, ROBERT J.DirectorBuy5,100
2024-02-08TRENSCHEL, ROBERT J.DirectorSale12,160
2024-02-08TRENSCHEL, ROBERT J.DirectorSale6,880
2024-02-08DIAZ, STEPHANIEDirectorSale6,980
2024-02-08DIAZ, STEPHANIEDirectorSale5,820
2024-02-08DIAZ, STEPHANIEDirectorBuy6,980
2024-02-08DIAZ, STEPHANIEDirectorBuy5,820
2024-02-08DIAZ, STEPHANIEDirectorBuy9,580
2024-02-08DIAZ, STEPHANIEDirectorBuy6,880
2024-02-08CSIMMA, CRISTINADirectorSale6,980
2024-02-08CSIMMA, CRISTINADirectorSale5,820
2024-02-08CSIMMA, CRISTINADirectorBuy6,980
2024-02-08CSIMMA, CRISTINADirectorBuy5,820
2024-02-08CSIMMA, CRISTINADirectorBuy9,580
2024-02-08CSIMMA, CRISTINADirectorBuy6,880
2024-02-06JONES, MITCHELL LAWRENCEChief Medical OfficerSale4,558
2024-02-06JONES, MITCHELL LAWRENCEChief Medical OfficerSale2,333
2024-02-06JONES, MITCHELL LAWRENCEChief Medical OfficerBuy4,558
2024-02-06JONES, MITCHELL LAWRENCEChief Medical OfficerBuy2,333
2024-02-06JONES, MITCHELL LAWRENCEChief Medical OfficerSale2,153$0.44$938.92
2024-02-06FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorSale3,475
2024-02-06FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorSale3,167
2024-02-06FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorBuy10,000$0.47$4692.00
2024-02-06FINLEY, JOHN DAVIDDirector, CEO, CFO, DirectorBuy3,475

Frequently asked questions

Are PALI insiders buying or selling?

Over the transactions on record, PALI insiders have been net buyers, with about $29206.61 in stock sold across 39 sales, against 6 open-market purchases.

Does insider selling at PALI mean the stock will fall?

Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.

Which PALI insiders are selling the most?

Recent selling is concentrated in a few names. FINLEY, JOHN DAVID accounts for the largest share on record, with about $17577.96 sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.